{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:47:20Z","timestamp":1785336440549,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,12,5]],"date-time":"2003-12-05T00:00:00Z","timestamp":1070582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,12,5]],"date-time":"2003-12-05T00:00:00Z","timestamp":1070582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/ar1032","type":"journal-article","created":{"date-parts":[[2003,12,16]],"date-time":"2003-12-16T12:41:21Z","timestamp":1071578481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus"],"prefix":"10.1186","volume":"6","author":[{"given":"Christopher","family":"Sj\u00f6wall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders A","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Sturfelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Skogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,12,5]]},"reference":[{"key":"1022_CR1","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1002\/1529-0131(199810)41:10<1714::AID-ART3>3.0.CO;2-U","volume":"41","author":"GS Cooper","year":"1998","unstructured":"Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Parks CG, Gilkeson GS: Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum. 1998, 41: 1714-1724. 10.1002\/1529-0131(199810)41:10<1714::AID-ART3>3.3.CO;2-L.","journal-title":"Arthritis Rheum"},{"key":"1022_CR2","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1046\/j.1365-2222.2001.01147.x","volume":"31","author":"MG Robson","year":"2001","unstructured":"Robson MG, Walport MJ: Pathogenesis of systemic lupus erythematosus. Clin Exp Allergy. 2001, 31: 678-685. 10.1046\/j.1365-2222.2001.01147.x.","journal-title":"Clin Exp Allergy"},{"key":"1022_CR3","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/art.11025","volume":"48","author":"TW Du Clos","year":"2003","unstructured":"Du Clos TW: C-reactive protein as a regulator of autoimmunity and inflammation. Arthritis Rheum. 2003, 48: 1475-1477. 10.1002\/art.11025.","journal-title":"Arthritis Rheum"},{"key":"1022_CR4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S1471-4906(03)00030-9","volume":"24","author":"AJ Nauta","year":"2003","unstructured":"Nauta AJ, Daha MR, Kooten C, Roos A: Recognition and clearance of apoptotic cells: a role for complement and pentraxins. Trends Immunol. 2003, 24: 148-154. 10.1016\/S1471-4906(03)00030-9.","journal-title":"Trends Immunol"},{"key":"1022_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0167-5699(95)80069-7","volume":"16","author":"S Nagata","year":"1995","unstructured":"Nagata S, Suda T: Fas and Fas ligand: lpr and gld mutations. Immunol Today. 1995, 16: 39-43. 10.1016\/0167-5699(95)80069-7.","journal-title":"Immunol Today"},{"key":"1022_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/76032","volume":"25","author":"M Napirei","year":"2000","unstructured":"Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, Moroy T: Features of systemic lupus erythematosus in DNase1-deficient mice. Nat Genet. 2000, 25: 177-181. 10.1038\/76032.","journal-title":"Nat Genet"},{"key":"1022_CR7","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.4049\/jimmunol.152.7.3685","volume":"152","author":"W Emlen","year":"1994","unstructured":"Emlen W, Niebur J, Kadera R: Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol. 1994, 152: 3685-3692.","journal-title":"J Immunol"},{"key":"1022_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/ng0598-56","volume":"19","author":"M Botto","year":"1998","unstructured":"Botto M, Dell'Agnola C, Bygrave AE, Petry F, Loos M, Pandolfi PP, Walport MJ: Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet. 1998, 19: 56-59.","journal-title":"Nat Genet"},{"key":"1022_CR9","doi-asserted-by":"publisher","first-page":"5963","DOI":"10.4049\/jimmunol.167.10.5963","volume":"167","author":"Y Shoshan","year":"2001","unstructured":"Shoshan Y, Shapira I, Toubi E, Frolkis I, Yaron M, Mevorach D: Accelerated Fas-mediated apoptosis of monocytes and maturing macrophages from patients with systemic lupus erythematosus: relevance to in vitro impairment of interaction with iC3b-opsonized apoptotic cells. J Immunol. 2001, 167: 5963-5969.","journal-title":"J Immunol"},{"key":"1022_CR10","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H","volume":"41","author":"M Herrmann","year":"1998","unstructured":"Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR: Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 1998, 41: 1241-1250. 10.1002\/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H.","journal-title":"Arthritis Rheum"},{"key":"1022_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0161-5890(01)00055-4","volume":"38","author":"Z Fishelson","year":"2001","unstructured":"Fishelson Z, Attali G, Mevorach D: Complement and apoptosis. Mol Immunol. 2001, 38: 207-219. 10.1016\/S0161-5890(01)00055-4.","journal-title":"Mol Immunol"},{"key":"1022_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/ard.62.1.1-a","volume":"62","author":"PJ Charles","year":"2003","unstructured":"Charles PJ: Defective waste disposal: does it induce autoanti-bodies in SLE?. Ann Rheum Dis. 2003, 62: 1-3. 10.1136\/ard.62.1.1-a.","journal-title":"Ann Rheum Dis"},{"key":"1022_CR13","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1002\/art.1780401210","volume":"40","author":"RE Voll","year":"1997","unstructured":"Voll RE, Roth EA, Girkontaite I, Fehr H, Herrmann M, Lorenz HM, Kalden JR: Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production. Arthritis Rheum. 1997, 40: 2162-2171.","journal-title":"Arthritis Rheum"},{"key":"1022_CR14","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1084\/jem.177.5.1367","volume":"177","author":"C Mohan","year":"1993","unstructured":"Mohan C, Adams S, Stanik V, Datta SK: Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med. 1993, 177: 1367-1381. 10.1084\/jem.177.5.1367.","journal-title":"J Exp Med"},{"key":"1022_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1177\/096120339500400202","volume":"4","author":"PE Spronk","year":"1995","unstructured":"Spronk PE, Limburg PC, Kallenberg CGM: Serological markers of disease activity in systemic lupus erythematosus. Lupus. 1995, 4: 86-94.","journal-title":"Lupus"},{"key":"1022_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/0952-7915(95)80029-8","volume":"7","author":"H Gewurz","year":"1995","unstructured":"Gewurz H, Zhang XH, Lint TF: Structure and function of the pentraxins. Curr Opin Immunol. 1995, 7: 54-64. 10.1016\/0952-7915(95)80029-8.","journal-title":"Curr Opin Immunol"},{"key":"1022_CR17","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/immu.200310022","volume":"33","author":"AJ Nauta","year":"2003","unstructured":"Nauta AJ, Bottazzi B, Mantovani A, Salvatori G, Kishore U, Schwaeble WJ, Gingras AR, Tzima S, Vivanco F, Egido J, Tijsma O, Hack EC, Daha MR, Roos A: Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. Eur J Immunol. 2003, 33: 465-473. 10.1002\/immu.200310022.","journal-title":"Eur J Immunol"},{"key":"1022_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0969-2126(99)80023-9","volume":"7","author":"D Thompson","year":"1999","unstructured":"Thompson D, Pepys MB, Wood SP: The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure Fold Des. 1999, 7: 169-177. 10.1016\/S0969-2126(99)80023-9.","journal-title":"Structure Fold Des"},{"key":"1022_CR19","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.4049\/jimmunol.156.11.4435","volume":"156","author":"M Motie","year":"1996","unstructured":"Motie M, Brockmeier S, Potempa LA: Binding of model soluble immune complexes to modified C-reactive protein. J Immunol. 1996, 156: 4435-4441.","journal-title":"J Immunol"},{"key":"1022_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1006\/jaut.2002.0615","volume":"19","author":"C Mold","year":"2002","unstructured":"Mold C, Baca R, Du Clos TW: Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fc\u03b3Rs. J Autoimmun. 2002, 19: 147-154. 10.1006\/jaut.2002.0615.","journal-title":"J Autoimmun"},{"key":"1022_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/BF00351177","volume":"23","author":"TW Du Clos","year":"1996","unstructured":"Du Clos TW: The interaction of C-reactive protein and serum amyloid P component with nuclear antigens. Mol Biol Rep. 1996, 23: 253-260. 10.1007\/BF00351177.","journal-title":"Mol Biol Rep"},{"key":"1022_CR22","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1084\/jem.192.9.1353","volume":"192","author":"D Gershov","year":"2000","unstructured":"Gershov D, Kim S, Brot N, Elkon KB: C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an anti-inflammatory innate immune response: implications for systemic autoimmunity. J Exp Med. 2000, 192: 1353-1364. 10.1084\/jem.192.9.1353.","journal-title":"J Exp Med"},{"key":"1022_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/00000441-200002000-00002","volume":"319","author":"EE Diehl","year":"2000","unstructured":"Diehl EE, Haines GK, Radosevich JA, Potempa LA: Immuno-histochemical localization of modified C-reactive protein antigen in normal vascular tissue. Am J Med Sci. 2000, 319: 79-83. 10.1097\/00000441-200002000-00002.","journal-title":"Am J Med Sci"},{"key":"1022_CR24","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S1357-2725(98)00078-8","volume":"30","author":"JJ Kresl","year":"1998","unstructured":"Kresl JJ, Potempa LA, Anderson BE: Conversion of native oligomeric to a modified monomeric form of human C-reactive protein. Int J Biochem Cell Biol. 1998, 30: 1415-1426. 10.1016\/S1357-2725(98)00078-8.","journal-title":"Int J Biochem Cell Biol"},{"key":"1022_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1006\/jaut.2002.0608","volume":"19","author":"C Sj\u00f6wall","year":"2002","unstructured":"Sj\u00f6wall C, Eriksson P, Almer S, Skogh T: Autoantibodies to C-reactive protein is a common finding in SLE, but not in primary Sj\u00f6gren's syndrome, rheumatoid arthritis or inflammatory bowel disease. J Autoimmun. 2002, 19: 155-160. 10.1006\/jaut.2002.0608.","journal-title":"J Autoimmun"},{"key":"1022_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1046\/j.1365-2249.1998.00655.x","volume":"113","author":"SA Bell","year":"1998","unstructured":"Bell SA, Faust H, Schmid A, Meurer M: Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases. Clin Exp Immunol. 1998, 113: 327-332. 10.1046\/j.1365-2249.1998.00655.x.","journal-title":"Clin Exp Immunol"},{"key":"1022_CR27","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE: Derivation of the SLEDAI. Arthritis Rheum. 1992, 35: 630-640.","journal-title":"Arthritis Rheum"},{"key":"1022_CR28","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1093\/rheumatology\/36.12.1283","volume":"36","author":"G Sturfelt","year":"1997","unstructured":"Sturfelt G, Roux-Lombard P, Wollheim FA, Dayer JM: Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in systemic lupus erythematosus. Br J Rheumatol. 1997, 36: 1283-1289. 10.1093\/rheumatology\/36.12.1283.","journal-title":"Br J Rheumatol"},{"key":"1022_CR29","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/0161-5890(87)90028-9","volume":"24","author":"LA Potempa","year":"1987","unstructured":"Potempa LA, Siegel JN, Fiedel BA, Potempa RT, Gewurz H: Expression, detection and assay of a neoantigen (Neo-CRP) associated with a free, human C-reactive protein subunit. Mol Immunol. 1987, 24: 531-541. 10.1016\/0161-5890(87)90028-9.","journal-title":"Mol Immunol"},{"key":"1022_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0076-6879(87)55023-6","volume":"155","author":"KB Mullis","year":"1987","unstructured":"Mullis KB, Faloona FA: Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol. 1987, 155: 335-350.","journal-title":"Methods Enzymol"},{"key":"1022_CR31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/art.1780390303","volume":"39","author":"D Gladman","year":"1996","unstructured":"Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardieri S, Hanly J, Hay E, Isenberg D, Jones J, Kalunian K, Maddison P, Nived O, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zoma A: The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996, 39: 363-369.","journal-title":"Arthritis Rheum"},{"key":"1022_CR32","first-page":"573","volume":"13","author":"H Jonsson","year":"1995","unstructured":"Jonsson H, Sturfelt G, M\u00e5rtensson U, Truedsson L, Sj\u00f6holm AG: Prospective analysis of C1 dissociation and complement activation in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 1995, 13: 573-580.","journal-title":"Clin Exp Rheumatol"},{"key":"1022_CR33","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00002281-200009000-00003","volume":"12","author":"Z Amoura","year":"2000","unstructured":"Amoura Z, Koutouzov S, Piette JC: The role of nucleosomes in lupus. Curr Opin Rheumatol. 2000, 12: 369-373. 10.1097\/00002281-200009000-00003.","journal-title":"Curr Opin Rheumatol"},{"key":"1022_CR34","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1172\/JCI116336","volume":"91","author":"DM Vigushin","year":"1993","unstructured":"Vigushin DM, Pepys MB, Hawkins PN: Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest. 1993, 91: 1351-1357.","journal-title":"J Clin Invest"},{"key":"1022_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000233593","volume":"75","author":"G Sturfelt","year":"1984","unstructured":"Sturfelt G, Sj\u00f6holm AG: Complement components, complement activation, and acute phase response in systemic lupus erythematosus. Int Archs Allergy Appl Immun. 1984, 75: 75-83.","journal-title":"Int Archs Allergy Appl Immun"},{"key":"1022_CR36","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.4049\/jimmunol.164.3.1514","volume":"164","author":"MP Stein","year":"2000","unstructured":"Stein MP, Mold C, Du Clos TW: C-reactive protein binding to murine leukocytes requires Fc\u03b3Rs. J Immunol. 2000, 164: 1514-1520.","journal-title":"J Immunol"},{"key":"1022_CR37","doi-asserted-by":"publisher","first-page":"40775","DOI":"10.1074\/jbc.M205378200","volume":"277","author":"T Khreiss","year":"2002","unstructured":"Khreiss T, Jozsef L, Hossain S, Chan JS, Potempa LA, Filep JG: Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils. J Biol Chem. 2002, 277: 40775-40781. 10.1074\/jbc.M205378200.","journal-title":"J Biol Chem"},{"key":"1022_CR38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/0008-8749(88)90212-2","volume":"116","author":"NL Samberg","year":"1988","unstructured":"Samberg NL, Bray RA, Gewurz H, Landay AL, Potempa LA: Preferential expression of neo-CRP epitopes on the surface of human peripheral blood lymphocytes. Cell Immunol. 1988, 116: 86-98. 10.1016\/0008-8749(88)90212-2.","journal-title":"Cell Immunol"},{"key":"1022_CR39","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.4049\/jimmunol.140.12.4271","volume":"140","author":"RA Bray","year":"1988","unstructured":"Bray RA, Samberg NL, Gewurz H, Potempa LA, Landay AL: C-reactive protein antigenicity on the surface of human peripheral blood lymphocytes. Characterization of lymphocytes reactive with anti-neo-CRP. J Immunol. 1988, 140: 4271-4278.","journal-title":"J Immunol"},{"key":"1022_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4049\/jimmunol.169.1.159","volume":"169","author":"BA Cocca","year":"2002","unstructured":"Cocca BA, Cline AM, Radic MZ: Blebs and apoptotic bodies are B cell autoantigens. J Immunol. 2002, 169: 159-166.","journal-title":"J Immunol"},{"key":"1022_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1191\/096120398678919804","volume":"7","author":"A Perniok","year":"1998","unstructured":"Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M: High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus. 1998, 7: 113-118. 10.1191\/096120398678919804.","journal-title":"Lupus"},{"key":"1022_CR42","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/ard.58.5.309","volume":"58","author":"PA Courtney","year":"1999","unstructured":"Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy AL, Bell AL: Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relation with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis. 1999, 58: 309-314.","journal-title":"Ann Rheum Dis"},{"key":"1022_CR43","first-page":"310","volume":"22","author":"M Pascual","year":"1995","unstructured":"Pascual M, Schifferli JA: Another function of erythrocytes: transport of circulating immune complexes. Infusionther Transfusionsmed. 1995, 22: 310-315.","journal-title":"Infusionther Transfusionsmed"},{"key":"1022_CR44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.1365-3083.2000.00752.x","volume":"52","author":"C Klint","year":"2000","unstructured":"Klint C, Gullstrand B, Sturfelt G, Truedsson L: Binding of immune complexes to erythrocyte CR1 (CD35): difference in requirement of classical pathway components and indication of alternative pathway-mediated binding in C2-deficiency. Scand J Immunol. 2000, 52: 103-108. 10.1046\/j.1365-3083.2000.00752.x.","journal-title":"Scand J Immunol"},{"key":"1022_CR45","first-page":"53","volume":"49","author":"T Skogh","year":"1983","unstructured":"Skogh T, Stendahl O: Complement-mediated delay in immune complex clearance from the blood owing to reduced deposition outside the reticuloendothelial system. Immunology. 1983, 49: 53-59.","journal-title":"Immunology"}],"container-title":["Arthritis Res Ther"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar1032.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar1032\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar1032.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T16:08:06Z","timestamp":1714061286000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar1032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,5]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2003,4]]}},"alternative-id":["1022"],"URL":"https:\/\/doi.org\/10.1186\/ar1032","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12,5]]},"assertion":[{"value":"28 September 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2003","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2003","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2003","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"R87"}}